![NCI-MATCH to Bring in Public, Private Funds, Giving NCI New Urgent Scientific Agenda](https://cdn.cancerletter.com/media/2015/06/26055424/41-22-James-Doroshow-1.jpg)
![NCI-MATCH to Bring in Public, Private Funds, Giving NCI New Urgent Scientific Agenda](https://cdn.cancerletter.com/media/2015/06/26055424/41-22-James-Doroshow-1.jpg)
Cover Story
ECOG-ACRIN Cancer Research Group is starting enrollment in NCI-MATCH, the most ambitious of NCI's new generation of clinical trials.
In Brief
Trending Stories
- Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Elizabeth Comen joins NYU Langone Health’s Perlmutter Cancer Center
- A modest proposal from a former FDA commissioner: Add antidepressants to the nation’s water supply
Warning: This is not a public health recommendation. Do not implement. - At Lung SPORE Workshop, experts reflect on the significance of discovery of EGFR mutations two decades ago
- The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop